Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Treatment of metastatic breast cancer is often unsuccessful and lead to 5000 deaths in Canada each year. Therefore, there is an unmet need for new drugs for prevention and/or treatment of metastatic disease. Ezrin is a protein marker commonly over-expressed in metastatic breast cancer. Preclinical studies show that blocking ezrin can significantly reduce metastasis in breast cancer models. In this proposal, the intern will develop novel biosensors to screen large numbers of compounds with the ability to block ezrins activity in cancer cells. The results of this project can be used to identify novel therapeutics to minimize metastasis in breast cancer. Additionally, the path to developing of new drugs can be expedited to clinical trials through our industry partner, Tika Therapeutics.
Peter Greer
Kazem Nouri
Tika Therapeutics Inc
Biochemistry / Molecular biology
Medical devices
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.